Braster S.A. Total Liabilities

Latest as of March 2024: zł23.68 Million PLN ≈ $6.52 Million USD

Braster S.A. total liabilities. Based on the latest financial reports, Braster S.A. (BRA) has total liabilities worth zł23.68 Million PLN (≈ $6.52 Million USD) as of March 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Braster S.A. (BRA) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Braster S.A. (2011–2023)

Total liabilities of Braster S.A. from 2011 to 2023. This chart illustrates how Braster S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore Braster S.A. long-term investment allocation to see how much of total assets are deployed in long-term investments.

Braster S.A. Competitors by Total Liabilities

The table below lists competitors of Braster S.A. ranked by their total liabilities.

Company Country Total Liabilities
Genesis Resources Ltd
AU:GES
Australia AU$22.73 Million
Ravi Kumar Distilleries Limited
NSE:RKDL
India Rs886.28 Million
Erika Carmel Ltd
TA:BCUR
Israel ILA18.11 Million
TaoWeave Inc.
NASDAQ:TWAV
USA $1.28 Million
Citatah Tbk
JK:CTTH
Indonesia Rp493.94 Billion
Asia Pacific Fibers Tbk
JK:POLY
Indonesia Rp1.11 Billion
Senti Biosciences Inc
NASDAQ:SNTI
USA $44.56 Million

Liability Composition Analysis (2011–2023)

This chart breaks down Braster S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BRA asset base.

Liquidity & Leverage Metrics

Braster S.A. Total Liabilities Ratios Explained

Braster S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.52 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -4.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Braster S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Braster S.A. (2011–2023)

The table below shows the annual total liabilities of Braster S.A. from 2011 to 2023.

Year Total Liabilities Change
2023-12-31 zł23.55 Million
≈ $6.48 Million
-0.46%
2022-12-31 zł23.65 Million
≈ $6.51 Million
+7.65%
2021-12-31 zł21.97 Million
≈ $6.05 Million
-21.46%
2020-12-31 zł27.97 Million
≈ $7.70 Million
-0.37%
2019-12-31 zł28.08 Million
≈ $7.73 Million
+10.06%
2018-12-31 zł25.51 Million
≈ $7.02 Million
+2.83%
2017-12-31 zł24.81 Million
≈ $6.83 Million
-17.29%
2016-12-31 zł30.00 Million
≈ $8.26 Million
+429.20%
2015-12-31 zł5.67 Million
≈ $1.56 Million
+17.81%
2014-12-31 zł4.81 Million
≈ $1.32 Million
+1015.18%
2013-12-31 zł431.41K
≈ $118.73K
+24.34%
2012-12-31 zł346.95K
≈ $95.49K
-50.18%
2011-12-31 zł696.40K
≈ $191.66K
--

About Braster S.A.

WAR:BRA Poland Medical Devices
Market Cap
$4.69 Million
zł17.04 Million PLN
Market Cap Rank
#28645 Global
#328 in Poland
Share Price
zł0.58
Change (1 day)
+0.00%
52-Week Range
zł0.58 - zł0.58
All Time High
zł28.50
About

Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more